Tag: ViiV Healthcare

GlaxoSmithKline launches its HIV drug in China

British pharmaceutical giant GlaxoSmithKline has officially launched its blockbuster triple-therapy HIV drug in China, pricing it lower than in neighboring markets

ViiV Healthcare localizes the manufacturing of dolutegravir in Russia

viiv healthcare
Three registration lots of dolutegravir manufactured at Servier Pharmaceutical Plant in Russia successfully passed stability tests and comparative dissolution kinetics tests